DSM NV | 39,053 Euro | -0,277 -0,70 % | |
| WKN: A0JLZ7 ISIN: NL0000009827 Ticker-Symbol: DSM2 | Frankfurt | 25.05.12 | 17:45 Uhr |
Branche ChemieAktienmarkt EURONEXT-100AEX |
|
| ||||||||||||||
| Zeit | Aktuelle Nachrichten | Leser | Medien | |
|---|---|---|---|---|
| 21.05. | DSM Composite Resins: Preiserhöhung für Harzportfolio in Europa | 4 | KunststoffWeb | |
| 21.05. | DSM N.V. : DSM commences tender offer for Kensey Nash | 55 | Thomson Reuters ONE | |
| Royal DSM (NYSE Euronext: DSM KON), the global Life Sciences and Materials Sciences company, announced today that its indirect wholly-owned subsidiary, Biomedical Acquisition Corporation, has commenced... Mehr lesen zu: DSM N.V. : DSM commences tender offer for Kensey Nash | ||||
| 18.05. | Berenberg Bank belässt DSM auf 'Hold' - Ziel 43 Euro | 146 | APA-dpa-AFX-Analyser | |
| Die Privatbank Berenberg hat die
Einstufung für DSM nach dem angekündigten Kauf des kanadischen
Herstellers von Omega-3-Fettsäuren Ocean Nutrition auf "Hold" mit
einem Kursziel von 43,00 Euro... Mehr lesen zu: Berenberg Bank belässt DSM auf 'Hold' - Ziel 43 Euro | ||||
| 18.05. | DSM Buys Ocean Nutrition Canada | 7 | Benzinga.com | |
| 18.05. | UPDATE 1-DSM buys Canadian dietary supplements firm | 2 | Reuters.com | |
| 18.05. | DSM buys Canadian dietary supplements firm | - | Reuters.com | |
| 18.05. | DSM Composite Resins schlägt bei UPR 90 Euro auf | - | EUWID | |
| 18.05. | DSM N.V. : DSM to acquire Ocean Nutrition Canada to expand its Nutritional Lipids growth platform | 76 | Thomson Reuters ONE | |
| DSM (NYSE Euronext: DSM KON) to acquire Ocean Nutrition Canada in an all-cash transaction Total enterprise value CAD 540 million (about €420 million) Ocean Nutrition Canada expected 2012 Net Sales:... Mehr lesen zu: DSM N.V. : DSM to acquire Ocean Nutrition Canada to expand its Nutritional Lipids growth platform | ||||
| 16.05. | DSM: Vertriebsvereinbarung mit Lumena New Materials | 4 | KunststoffWeb | |
| 14.05. | Merrill Lynch belässt DSM auf 'Neutral' | 68 | APA-dpa-AFX-Analyser | |
| Merrill Lynch hat die Einstufung für DSM
auf "Neutral" belassen. Die chinesische Wirtschaft werde im zweiten
Quartal nur noch mit einer Wachstumsrate von 7,6 Prozent statt zuvor
8,5 Prozent erwartet... Mehr lesen zu: Merrill Lynch belässt DSM auf 'Neutral' | ||||
| 14.05. | XETI CAPITAL ADJUSTMENT INFORMATION - 15.05.2012 - 1 | 15 | Xetra Newsboard | |
| FOLGENDE WERTPAPIERE WERDEN AM 14.05.2012 CUM KAPITALMASSNAHME UND AM
15.05.2012 EX KAPITALMASSNAHME GEHANDELT.
THE FOLLOWING SHARES ARE TRADED CUM CAPITAL ADJUSTMENT ON 14.05.2012
AND EX CAPITAL... Mehr lesen zu: XETI CAPITAL ADJUSTMENT INFORMATION - 15.05.2012 - 1 | ||||
| 14.05. | XFRA CAPITAL ADJUSTMENT INFORMATION - 15.05.2012 - 1 | 25 | Xetra Newsboard | |
| FOLGENDE WERTPAPIERE WERDEN AM 14.05.2012 CUM KAPITALMASSNAHME UND AM
15.05.2012 EX KAPITALMASSNAHME GEHANDELT.
THE FOLLOWING SHARES ARE TRADED CUM CAPITAL ADJUSTMENT ON 14.05.2012
AND EX CAPITAL... Mehr lesen zu: XFRA CAPITAL ADJUSTMENT INFORMATION - 15.05.2012 - 1 | ||||
| 11.05. | DSM N.V. : DSM appoints two new Supervisory Board members | 43 | Thomson Reuters ONE | |
| Royal DSM today announces that its Annual General Meeting of Shareholders has approved appointing Mrs. Victoria Haynes and Mrs. Eileen Kennedy as Supervisory Board members. DSM is very pleased to... Mehr lesen zu: DSM N.V. : DSM appoints two new Supervisory Board members | ||||
| 11.05. | DSM N.V. : DSM announces results of Annual General Meeting of Shareholders | 56 | Thomson Reuters ONE | |
| Royal DSM today held its Annual General Meeting of Shareholders. The following items were approved: Adoption of the Financial Statements for 2011 Adoption of the dividend for 2011 (see also separate... Mehr lesen zu: DSM N.V. : DSM announces results of Annual General Meeting of Shareholders | ||||
| 11.05. | DSM N.V. : Final dividend Royal DSM | 50 | Thomson Reuters ONE | |
| The DSM Annual General Meeting of Shareholders on 11 May 2012 passed a resolution to declare a dividend for 2011 of €1.45 per ordinary share of €1.50 par value. An interim dividend of €0.45 per ordinary... Mehr lesen zu: DSM N.V. : Final dividend Royal DSM | ||||
| 09.05. | Chemiekonzern DSM strebt weitere Akquisitionen an | 47 | dpa-AFX | |
| Dank einer zwei Milliarden Euro starken
Cash-Reserve und solider Quartalszahlen sieht sich der Chemiekonzern
DSM für weitere Zukäufe gut gerüstet. "Wir hoffen, noch einige gute
Projekte in diesem... Mehr lesen zu: Chemiekonzern DSM strebt weitere Akquisitionen an | ||||
| 08.05. | The Law Firm of Levi & Korsinsky, LLP Announces Investigation into Possible Breaches of Fiduciary Duty by the Board of Kensey Nash Corporation in Connection with the Sale of the Company to Royal DSM N.V. | 23 | PR Newswire | |
| NEW YORK, May 8, 2012 /PRNewswire/ --Levi & Korsinsky is investigating the Board of Directors of Kensey Nash Corporation ("Kensey Nash" or the "Company") (NASDAQ GS: KNSY) for possible breaches of... Mehr lesen zu: The Law Firm of Levi & Korsinsky, LLP Announces Investigation into Possible Breaches of Fiduciary Duty by the Board of Kensey Nash Corporation in Connection with the Sale of the Company to Royal DSM N.V. | ||||
| 08.05. | DSM N.V. : DSM reports positive start to the year with robust Q1 results | 83 | Thomson Reuters ONE | |
| Q1 EBITDA from continuing operations €306 million (Q1 2011: €325 million) Strong results in Life Sciences due to continued growth in Nutrition Materials Sciences showed strong improvement compared... Mehr lesen zu: DSM N.V. : DSM reports positive start to the year with robust Q1 results | ||||
| 04.05. | The Law Firm of Levi & Korsinsky, LLP Announces Investigation into Possible Breaches of Fiduciary Duty by the Board of Kensey Nash Corporation in Connection with the Sale of the Company to Royal DSM N.V. | 42 | Business Wire | |
| Levi & Korsinsky is investigating the Board of Directors of Kensey Nash
Corporation ("Kensey Nash" or the "Company") (NASDAQ GS: KNSY) for
possible breaches of fiduciary... Mehr lesen zu: The Law Firm of Levi & Korsinsky, LLP Announces Investigation into Possible Breaches of Fiduciary Duty by the Board of Kensey Nash Corporation in Connection with the Sale of the Company to Royal DSM N.V. | ||||
| 03.05. | The Law Firm of Levi & Korsinsky, LLP Announces Investigation into Possible Breaches of Fiduciary Duty by the Board of Kensey Nash Corporation in Connection with the Sale of the Company to Royal DSM N.V. | 28 | Business Wire | |
| Levi & Korsinsky is investigating the Board of Directors of Kensey Nash
Corporation ("Kensey Nash" or the "Company") (NASDAQ GS: KNSY) for
possible breaches of fiduciary... Mehr lesen zu: The Law Firm of Levi & Korsinsky, LLP Announces Investigation into Possible Breaches of Fiduciary Duty by the Board of Kensey Nash Corporation in Connection with the Sale of the Company to Royal DSM N.V. | ||||
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten |
|---|---|---|---|
| BASF SE | 57,05 | -0,05 % | Kids X-Press Magazine Goes Global / BASF Uses Its Global Network to Foster a Science Magazine Written by Kids for Kids |
| BAYER AG | 50,90 | +0,89 % | DAX wieder über 6.300 Punkten: Aixtron, Bayer, Commerzbank, Dt. Post, EADS, Facebook im Fokus |
| LANXESS AG | 52,05 | -2,62 % | Börsenwelt Presseschau I: Lanxess und Leoni unter der Lupe |
| K+S AG | 33,000 | -0,90 % | K+S: Wann platzt der Konten? |
| LINDE AG | 122,40 | -0,16 % | Goldman hebt Ziel für Linde auf 160 Euro - 'Neutral' |
Startseite • Nachrichten • Aktienkurse • Xetra-Orderbuch • Watchlist
Ad hoc-Mitteilungen • Chartanalysen • Nachrichten Börsen • Aktien-Empfehlungen
Branchen • Medien • Nachrichten-Archiv
Impressum | AGB | Disclaimer • Presse • Mediadaten
RSS-News von FinanzNachrichten.de kostenlos für Ihren Browser und Ihre Homepage
